These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8847537)

  • 1. Old and new dopamine agonists in Parkinson's disease. Proceedings of an international congress. Pisa, Italy, December 1993.
    J Neural Transm Suppl; 1995; 45():1-321. PubMed ID: 8847537
    [No Abstract]   [Full Text] [Related]  

  • 2. Old and New Dopamine Agonists in Parkinson's Disease: a Reappraisal. Proceedings of the LIMPE Seminar, 26-28 February, Pisa, Italy, 2009.
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S1-115. PubMed ID: 20882687
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of early Parkinson's disease.
    Dickerson LM; Young SE; Simpson WM; Nashelsky J
    Am Fam Physician; 2005 Aug; 72(3):497-500. PubMed ID: 16100865
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved therapies for Parkinson's disease: life beyond dopamine D2/D3 receptor agonists.
    Williams M; Wright S; Lloyd GK
    Trends Pharmacol Sci; 1997 Sep; 18(9):307-10. PubMed ID: 9345846
    [No Abstract]   [Full Text] [Related]  

  • 5. Newer therapies for Parkinson's disease.
    Korczyn AD; Nisipeanu P
    Neurol Neurochir Pol; 1996; 30 Suppl 2():105-11. PubMed ID: 9100248
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine receptor agonists in the therapy of Parkinson's disease.
    Foley P; Gerlach M; Double KL; Riederer P
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1375-446. PubMed ID: 15480844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclamol. A "designer drug" in the treatment of advanced Parkinson's disease.
    Pirtosek Z; Merello M; Carlsson A; Stern G
    Adv Neurol; 1996; 69():535-40. PubMed ID: 8615177
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroprotection in Parkinson's disease.
    Montastruc JL; Rascol O; Senard JM
    Lancet; 1996 Jan; 347(8995):196. PubMed ID: 8544568
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controversial issues concerning the initial treatment of Parkinson's disease: L-Dopa or dopaminergic agonists?].
    Defer GL
    Rev Neurol (Paris); 1999 Jan; 155(1):43-5. PubMed ID: 10093847
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 11. [The agonist of dopamine receptors piribedil in treatment of Parkinson's disease].
    Pilipovich AA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):83-90. PubMed ID: 28745677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease.
    Ceravolo R; Rossi C; Del Prete E; Bonuccelli U
    Expert Opin Drug Saf; 2016; 15(2):181-98. PubMed ID: 26646536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK's Requip slow the loss of dopamine function in Parkinson's disease.
    Aviat Space Environ Med; 2002 Jul; 73(7):733. PubMed ID: 12137117
    [No Abstract]   [Full Text] [Related]  

  • 14. Slowing Parkinson's disease progression: recent dopamine agonist trials.
    Montgomery EB
    Neurology; 2004 Jan; 62(2):343; author reply 343-5. PubMed ID: 14745094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson's disease: use of piribedil].
    Gekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):54-6. PubMed ID: 14870695
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic agonists in the treatment of Parkinson's disease: a review.
    Piccoli F; Riuggeri RM
    J Neural Transm Suppl; 1995; 45():187-95. PubMed ID: 8748625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drugs in the treatment of Parkinson's disease. An introduction.
    Bracco F
    Adv Neurol; 1996; 69():513-7. PubMed ID: 8615173
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of piribedil in early and late stages of Parkinson's disease].
    Fedorova NV; Kulua TK; Gubanova ЕN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):96-98. PubMed ID: 26525631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching and combining dopamine agonists.
    Reichmann H; Herting B; Mïller A; Sommer U
    J Neural Transm (Vienna); 2003 Dec; 110(12):1393-400. PubMed ID: 14666411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.